Cohort Studyhigh evidence

Dietary index for gut microbiota, plasma metabolome, and risks of metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases.

Nutrition & metabolism·June 19, 2026·PMID 42321912

Why it matters

This study provides evidence that a gut microbiota–friendly diet may reduce liver disease risk, offering a potential preventive strategy for clinicians managing patients at risk for MASLD and related conditions.

Infographic summary of Dietary index for gut microbiota, plasma metabolome, and risks of metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled